Loading...
XNAS
LFCR
Market cap171mUSD
Jul 09, Last price  
4.75USD
1D
3.94%
1Q
0.00%
Jan 2017
-65.58%
Name

Lifecore Biomedical Inc

Chart & Performance

D1W1MN
XNAS:LFCR chart
P/E
P/S
1.38
EPS
Div Yield, %
Shrs. gr., 5y
4.99%
Rev. gr., 5y
5.12%
Revenues
129m
+0.46%
210,498,000238,527,000235,938,000238,224,000276,729,000317,552,000441,708,000476,813,000539,257,000541,099,000532,257,000524,227,000557,559,000160,066,000100,874,000111,270,000103,269,000128,261,000128,867,000129,464,593
Net income
-31m
L-20.47%
29,189,00013,542,0007,730,0003,984,0003,920,00012,696,00022,587,00019,145,00013,544,000-11,641,00010,590,00024,829,0002,122,000-38,191,000-32,294,000-116,715,000-99,563,00012,013,000-38,717,000-30,790,291
CFO
13m
P
-2,062,00017,520,0009,435,0007,483,00014,469,00022,181,00021,230,00021,045,00026,155,00021,784,00029,327,00019,779,00016,020,000-17,041,00016,471,000-22,593,000-17,441,000257,000-206,00012,565,716

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
IPO date
Feb 15, 1996
Employees
689
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT